110 related articles for article (PubMed ID: 27903230)
1. Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy.
Di Silvestre A; Lucafo M; De Iudicibus S; Ventura A; Martelossi S; Stocco G; Decorti G
Mini Rev Med Chem; 2017; 17(8):657-666. PubMed ID: 27903230
[TBL] [Abstract][Full Text] [Related]
2. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.
De Iudicibus S; Franca R; Martelossi S; Ventura A; Decorti G
World J Gastroenterol; 2011 Mar; 17(9):1095-108. PubMed ID: 21448414
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid action and the development of selective glucocorticoid receptor ligands.
Cole TJ
Biotechnol Annu Rev; 2006; 12():269-300. PubMed ID: 17045197
[TBL] [Abstract][Full Text] [Related]
5. Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective.
Ayroldi E; Macchiarulo A; Riccardi C
FASEB J; 2014 Dec; 28(12):5055-70. PubMed ID: 25205742
[TBL] [Abstract][Full Text] [Related]
6. [The mechanism of glucocorticoid resistance in multiple sclerosis].
Rzazewska-Makosa B
Postepy Hig Med Dosw (Online); 2005 Sep; 59():457-63. PubMed ID: 16177666
[TBL] [Abstract][Full Text] [Related]
7. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
Vandevyver S; Dejager L; Tuckermann J; Libert C
Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
[TBL] [Abstract][Full Text] [Related]
8. 5α-Reduced glucocorticoids: a story of natural selection.
Nixon M; Upreti R; Andrew R
J Endocrinol; 2012 Feb; 212(2):111-27. PubMed ID: 21903862
[TBL] [Abstract][Full Text] [Related]
9. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
[TBL] [Abstract][Full Text] [Related]
10. Generalized and tissue specific glucocorticoid resistance.
Martins CS; de Castro M
Mol Cell Endocrinol; 2021 Jun; 530():111277. PubMed ID: 33864884
[TBL] [Abstract][Full Text] [Related]
11. Dominance of the strongest: inflammatory cytokines versus glucocorticoids.
Dejager L; Vandevyver S; Petta I; Libert C
Cytokine Growth Factor Rev; 2014 Feb; 25(1):21-33. PubMed ID: 24412262
[TBL] [Abstract][Full Text] [Related]
12. There goes the neighborhood: Assembly of transcriptional complexes during the regulation of metabolism and inflammation by the glucocorticoid receptor.
Greulich F; Hemmer MC; Rollins DA; Rogatsky I; Uhlenhaut NH
Steroids; 2016 Oct; 114():7-15. PubMed ID: 27192428
[TBL] [Abstract][Full Text] [Related]
13. An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance.
Ingawale DK; Mandlik SK; Patel SS
J Complement Integr Med; 2015 Mar; 12(1):1-13. PubMed ID: 25503867
[TBL] [Abstract][Full Text] [Related]
14. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.
Martens C; Bilodeau S; Maira M; Gauthier Y; Drouin J
Mol Endocrinol; 2005 Apr; 19(4):885-97. PubMed ID: 15591535
[TBL] [Abstract][Full Text] [Related]
15. Optimized glucocorticoid therapy: teaching old drugs new tricks.
Strehl C; Buttgereit F
Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
[TBL] [Abstract][Full Text] [Related]
16. Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease.
Galliher-Beckley AJ; Cidlowski JA
IUBMB Life; 2009 Oct; 61(10):979-86. PubMed ID: 19787703
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma.
Thomas AL; Coarfa C; Qian J; Wilkerson JJ; Rajapakshe K; Krett NL; Gunaratne PH; Rosen ST
Nucl Recept Signal; 2015; 13():e006. PubMed ID: 26715915
[TBL] [Abstract][Full Text] [Related]
18. Sulfasalazine sensitises human monocytic/macrophage cells for glucocorticoids by upregulation of glucocorticoid receptor alpha and glucocorticoid induced apoptosis.
Oerlemans R; Vink J; Dijkmans BA; Assaraf YG; van Miltenburg M; van der Heijden J; Ifergan I; Lems WF; Scheper RJ; Kaspers GJ; Cloos J; Jansen G
Ann Rheum Dis; 2007 Oct; 66(10):1289-95. PubMed ID: 17267514
[TBL] [Abstract][Full Text] [Related]
19. Interplay of the inflammatory and stress systems in a hepatic cell line: interactions between glucocorticoid receptor agonists and interleukin-6.
Visser K; Smith C; Louw A
Endocrinology; 2010 Nov; 151(11):5279-93. PubMed ID: 20881254
[TBL] [Abstract][Full Text] [Related]
20. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R
Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
